Together with experts from hearing clinics, we set out the requirements that form the basis for our tendering procedures for hearing aids. After Amgros has set up a framework agreement with a supplier, we help the public hearing clinics by following up on stock control and deliveries of hearing aids to citizens. Therefore, we maintain close dialogue with hearing clinics, both to strengthen our collaboration and in order to keep up to date with developments in the area.
The Danish Medicines Council decides whether the public hospitals should use a new medicine or a new indication for an existing medicine as a possible standard treatment.
Amgros has been supplying health economic analyses and negotiating prices for the Medicines Council since the Medicines Council was established in 2017. Since 1 January 2020, the Danish Medicines Council has taken over the task of assessing the health economic analyses and on 1 January 2021, the Danish Medicines Council started applying the internationally recognised measurement unit QALY (quality-adjusted life years) in health economic assessments of new medicines.
In connection with the assessments of new medicines by the Danish Medicines Council, Amgros negotiates the price of the medicine with the applicant. Cooperation ensures that new medicines are recommended at a reasonable price in relation to their clinical effect. Link to negotiations page.
Amgros and the Danish Medicines Council work together to develop and streamline processes so that hospitals can start using new medicines very quickly.
Manufacturers and suppliers of pharmaceuticals, medical devices and hearing aids from all over the world are important partners for Amgros. It is in everybody's interest that as many suppliers as possible want to market their products on the Danish market.
We have a close dialogue with suppliers and their trade associations. We listen to their needs and balance solutions so that they are attractive for both them and us. This applies when we organise tendering procedures, when we optimise security of supply and when we negotiate prices of new pharmaceuticals.
Together we are larger and stronger. This is the fundamental philosophy behind our work with players in other countries. Denmark is a small country with a small market, but with other countries, we can enhance our position and become a stronger cooperation partner for suppliers. At the same time, suppliers can be part of a bigger market. This should benefit all parties.READ MORE
In a complex landscape with many players, our focus is on securing solid operations, while at the same time thinking innovatively and being flexible and agile.READ MORE